It would not be valued by markets but private entities that would have interest in it. Upon FDA approval, it will have market value based on value of its products, earnings or the competition or purchase offers. Prior to approval, the patents and the capital R&D cost define its value.
I do not believe that the public market has valued it correctly right now. And that is the reason for it to private.
News 
Market Data 
Discover 
AI
